These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. THE PNEUMOCOCCAL POLYSACCHARIDES. HOW MJ; BRIMACOMBE JS; STACEY M Adv Carbohydr Chem; 1964; 19():303-58. PubMed ID: 14272331 [No Abstract] [Full Text] [Related]
4. Persistence of antibodies in human subjects injected with pneumococcal polysaccharides. HEIDELBERGER M; DILAPI MM; SIEGEL M; WALTER AW J Immunol; 1950 Nov; 65(5):535-41. PubMed ID: 14794919 [No Abstract] [Full Text] [Related]
5. Degradation of pneumococcal polysaccharides S3 and S8 by inducible depolymerases from Bacillus palustris. TORRIANI A; PAPPENHEIMER AM Bull Soc Chim Biol (Paris); 1960; 42():1619-26. PubMed ID: 13777587 [No Abstract] [Full Text] [Related]
6. The cross-reactivity of ketha gum and pneumococcal type I--short cut to a constituent of a polysaccharide. HEIDELBERGER M; TYLER JM; MUKHERJEE S Immunology; 1962 Nov; 5(6):666-72. PubMed ID: 13953335 [TBL] [Abstract][Full Text] [Related]
7. A BIOASSAY FOR ESTIMATION OF PNEUMOCOCCAL POLYSACCHARIDE IN UNRESPONSIVE (PARALYZED) MICE. SISKIND GW; PATERSON PY J Immunol; 1964 Sep; 93():489-94. PubMed ID: 14218610 [No Abstract] [Full Text] [Related]
8. Comparison between the specificity of antibodies to pneumococcal polysaccharides S3 and S8 and the induced S3- and S8-depolymerases of Bacillus palustris. CAMPBELL JH; PAPPENHEIMER AM Ann N Y Acad Sci; 1963 May; 103():1014-26. PubMed ID: 14018138 [No Abstract] [Full Text] [Related]
9. MECHANISMS OF IMMUNOLOGIC PARALYSIS BY PNEUMOCOCCAL POLYSACCHARIDE. IV. COMPARISON OF POLYSACCHARIDE AND WHOLE ORGANISMS. NEEPER CA; SEASTONE CV J Immunol; 1964 Nov; 93():867-71. PubMed ID: 14239947 [No Abstract] [Full Text] [Related]
10. INDUCTION OF UNRESPONSIVENESS AND IMMUNITY IN NEWBORN AND ADULT MICE WITH PNEUMOCOCCAL POLYSACCHARIDE. SISKIND GW; PATERSON PY; THOMAS L J Immunol; 1963 Jun; 90():929-34. PubMed ID: 14050203 [No Abstract] [Full Text] [Related]
11. Studies in bacterial allergy. VI. Hapten aerosol desensitization of guinea pigs passively sensitized to specific pneumococcal polysaccharides. SWINEFORD O J Allergy; 1954 May; 25(3):260-9. PubMed ID: 13151799 [No Abstract] [Full Text] [Related]
12. MECHANISMS OF IMMUNOLOGIC PARALYSIS BY PNEUMOCOCCAL POLYSACCHARIDE. 3. IMMUNOLOGIC PARALYSIS IN RELATION TO MATURATION OF THE IMMUNOLOGIC RESPONSE OF MICE. NEEPER CA J Immunol; 1964 Nov; 93():860-6. PubMed ID: 14239946 [No Abstract] [Full Text] [Related]
13. Quantification of C-polysaccharide in Streptococcus pneumoniae polysaccharides by high-performance anion-exchange chromatography with pulsed amperometric detection. Talaga P; Moreau M Dev Biol (Basel); 2000; 103():27-34. PubMed ID: 11214250 [TBL] [Abstract][Full Text] [Related]
15. The application of the falling drop technic; the quantitative determination of pneumococcal polysaccharide. LIPTON MM J Immunol; 1948 Jul; 59(3):263-8. PubMed ID: 18865900 [No Abstract] [Full Text] [Related]
16. Differences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations. Palkola NV; Pakkanen SH; Kantele JM; Pakarinen L; Puohiniemi R; Kantele A J Infect Dis; 2015 Oct; 212(8):1279-87. PubMed ID: 25838267 [TBL] [Abstract][Full Text] [Related]
17. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845 [TBL] [Abstract][Full Text] [Related]
18. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. Anttila M; Eskola J; Ahman H; Käyhty H J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841 [TBL] [Abstract][Full Text] [Related]